Farzaneh Ashrafi
Assistant Professor, Department of Hematology-Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
[ 1 ] - Efficacy of Rituximab in the Treatment of Plasma Exchange Refractory Thrombotic Thrombocytopenic Purpura
Background: Rituximab can induce a durable remission in plasma exchange refractory thrombotic thrombocytopenic purpura (TTP). Timing of Rituximab infusion in combination with plasma exchange (PE) and long term follow-up for probable side effects of such treatment is still lacking. Methods: This study was conducted among 10 patients with plasma exchange refractory TTP. According to the study de...
نویسندگان همکار